Objective. Cardiac hexokinase II (HKII) can translocate between cytosol and mitochondria and change its cellular expression with pathologies such as ischemia-reperfusion, diabetes and heart failure. The cardiac metabolic consequences of these changes are unknown. Here we measured energy substrate utilization in cytosol and mitochondria using stabile isotopes and oxygen consumption of the intact perfused heart for 1) an acute decrease in mitochondrial HKII (mtHKII), and 2) a chronic decrease in total cellular HKII.
Introduction
The glycolytic enzyme hexokinase (HK) facilitates the immediate phosphorylation of glucose upon entering the cell, thereby trapping glucose within the cell. The heart mainly contains the isoforms HK I and II, in approximately equal amounts [1] . HKI is present in almost all cells, mainly localized at the outer mitochondrial membrane, and hardly regulated by hormonal or metabolic signals. In contrast, HKII is mostly present in insulin-sensitive tissue (skeletal muscle, adipose tissue, heart) with its activity, expression and cellular localization (cytosolic or mitochondrial) highly regulated by hormonal or metabolic signals, and responsive to pathological conditions such as diabetes, heart failure, cancer and ischemia-reperfusion (IR) [2] [3] [4] [5] [6] [7] .
It remains unclear, however, what the metabolic consequences are of decreased mitochondrial HKII (mtHKII) or decreased total cardiac HKII on energy substrate selection and oxygen consumption within the intact heart. Fueger et al [8, 9] did show a reduced cardiac glucose uptake during exercise or an insulin clamp in in vivo HKII +/-as compared to wild-type hearts, but cellular glucose metabolism was not further studied. Cellular studies have suggested increased activity of HK when bound to mitochondria, due to privileged access to mitochondrially-produced ATP [10] . Binding of HKII to mitochondria resulted in increased glycolysis in isolated cell cultures provided with glucose-only substrate, whereas cytosolic HKII did not contribute to glycolysis [11, 12] . Whether these data would directly translate to similar effects (i.e. decreased glycolysis and/or glucose oxidation with decreased mtHKII) in the intact heart with high energy turnover and supplied with several substrates remains to be examined.
In addition, it is now well established that reductions in mtHKII makes the heart sensitive to IR injury [5, 13, 14] . Several mechanisms have been proposed to explain how diminished mtHKII in tissues or organs can increase sensitivity to IR damage [5, 12, 14] . One putative mechanism figuring prominently in IR injury, is the activity of the respiratory chain, activation of which often results in increased IR injury [15, 16] . No information is currently available whether decreased cardiac mtHKII,
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4 either acutely or chronically, actually results in increased respiratory activity (oxygen consumption)
within the intact heart. Accordingly, herein we examine the cardiac metabolic consequences of alterations in expression and cellular localization of HKII. Cardiac oxygen consumption and energy substrate metabolism in cytosol and mitochondria were determined in isolated heart models during perfusion conditions that were previously shown to have reduced mtHKII, i.e. 1) acutely through peptide treatment disrupting mtHKII binding in the presence of glucose, lactate and pyruvate [17] , or 2) chronically through deletion of one HKII copy in the presence of glucose, lactate, pyruvate, insulin and fatty acids (FFA) [17, 18] . Cardiac metabolism of both heart models was determined using either stable isotope labeled glucose or stable isotope labeled palmitate to assess relevant metabolic fluxes using mass isotopomer distribution analysis [19] . To further examine whether cardiac metabolism is sensitive to the total amount of HKII chronically present, metabolic programming at the transcriptional level was compared between HKII +/-and WT hearts using RNA sequencing.
In the present study we hypothesize that within the intact heart 1) acute decreases in mtHKII are associated with decreased glucose breakdown and increased oxygen consumption, 2) chronic decreases in total and mtHKII result in altered cardiac metabolism (glucose and fatty acid breakdown), oxygen consumption, and differential (metabolic) gene transcription.
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Methods

Animals
C57BL/6J HKII +/- [20] and their wild-type (WT) littermates were obtained from the in house breeding facility, as reported before [17] . The wild-type (WT) mice in the TAT-HKII series were all C57BL/6J and obtained from Charles River. Experiments were performed with male mice between 2-4 months old. All experiments were approved by the animal ethics committee of the Academic Medical Center, Amsterdam, The Netherlands. Although the experimenter at the day of experiment was aware of genotype and peptide treatment (this was inherent to the execution of the experiment because the experimenter had to select the animals from the breeding facility and make the peptide solution), all results assessed (metabolic, mechanical) were performed in a blinded fashion.
Heart Perfusion
Mice were heparinized (15 IU) and anesthetized with pentobarbital (80 mg kg -1 ). Following tracheotomy, the mice were mechanically ventilated and a thoracotomy performed. The hearts were cannulated in situ with perfusion started before excision of the heart. Hearts were Langendorffperfused at a constant flow (initial perfusion pressure 80 mm Hg) at 37C with non-recirculating was set at ~4-8 mmHg using a water-filled polyethylene balloon inserted into the left ventricular (LV) cavity via the mitral valve. The hearts were continuously submerged in 37C perfusate. LV developed pressure was calculated as the systolic pressure (Psys) minus EDP. The rate-pressure product (RPP, index of mechanical performance) was the product of the developed LV pressure and the heart rate.
Following stabilization of LV pressure, all hearts were perfused for 30 min, starting at baseline (t=0 
insulin and fatty acids. This allowed evaluation of the role of HKII for cardiac metabolism within a high metabolic contextance.
Mass isotopomer distribution analysis
The isotope distribution of lactate, pyruvate and citric acid cycle intermediates was determined in heart tissue freeze clamped after Langendorff perfusion. Heart tissue (~100 mg wet weight) was homogenized in 1 mL 8% (w/v) sulfosalicylic acid and 100 μL of internal standard (0.2 mM 2-phenylbutyric acid) using an Ultra-Turrax and sonication or the Tissuelyser (Qiagen). The resulting suspension was centrifuged (10 minutes, 12000 g), after which the pH of the supernatant was adjusted to 7 by adding 30% NaOH dropwise. The sample was then split in two. In half of the extract the keto groups were directly oximated by addition of 50 μL 5M hydroxylamine hydrochloride and incubation at 60°C for 30 minutes. The other half of the extract was first reduced by 50 μL 200 mM NaBH 4 , and incubated at room temperature for 30 minutes. After inactivation and neutralization using hydrochloric acid and KOH/MOPS, respectively, the sample was further treated with citrate lyase and hydroxylamine, to convert citrate into oximated oxaloacetate (750 μL of 500 mM triethylamine pH 7.4, 100 mM MgSO 4 , 50 mM EDTA, 10 μL 5M hydroxylamine hydrochloride and 2.5U citrate lyase). The mixture was sonicated and incubated for 5 minutes at 37°C after which the sample was acidified by adding 100 μL saturated sulfosalicylic acid and centrifuged (10 minutes, 1200 g). Next, both samples were reacidified by adding 100 μL 37% HCl, and saturated with salt by adding ~0.2 g NaCl. The organic acids were extracted twice by adding 3 mL ethylacetate. Both ethylacetate extracts were pooled and dried. The residue was derivatized by addition of 75 μL N-tertbutyldimethylsilyl-N-methyltrifluoroacetamide, and incubation at 80°C for 60 minutes. Within 24
hours, the sample (1 μL) was analyzed by gas chromatography-mass spectrometry (GC-MS). Peak intensities were integrated, corrected for natural abundance, and used for the calculation of
contribution of glucose and palmitate to acetyl-CoA formation for citrate synthesis [19] .
Concentrations of citric acid, 2-ketoglutaric acid, malic acid, lactic acid, succinic acid, pyruvic acid and fumaric acid were determined using 0.2 mM 2-phenylbutyric acid as internal standard.
All hearts in the TAT series were perfused with [U- 
RNA isolation and RNA sequencing analysis
RNA was isolated from 6 WT and 6 HKII +/-hearts using QIAzol lysis reagent followed by cleaned up using the RNeasy kit. RNA samples were submitted to the Genomics Core Facility at the Icahn were generated by aligning the fastq files to the mouse genome mm10 (UCSC) with STAR and then using featureCounts to count overlaps with exons. Final counts were grouped at the gene level [22] .
Outlier detection identified 2 samples (1 WT and 1 HKII +/-), which were removed from subsequent analysis. Differential expression analysis was conducted with R the packages limma (with voom transformation) [23] and DESeq2 [24] (Love et al, 2014). Low count genes were removed in the limma analysis, genes were kept if they had at least one count per million in at least 5 samples. A false discovery rate (Benjamini-Hochberg) of 0.05 was chosen as the cut off.
Statistics
Values are presented as mean ± SEM. Differences between TAT and TATHKII groups for mechanical performance and oxygen consumption were analysed by a two-way ANOVA for repeated measurements followed by contrast comparison (SPSS version 23). Differences between groups were analyzed with paired or unpaired Student's t-test when applicable. Differences were considered statistically significant at P<0.05.
Results
Functional effects of acute detachment of HKII using TATHKII peptide treatment in ex vivo
Langendorff hearts
The impact of 25 min TATHKII peptide treatment was compared with that of control, the TAT peptide ( Figure 1 ). Peak systolic ventricular pressure (Fig. 1A) and RPP (Fig. 1C) showed a moderate decrease over time in the control group, probably as a result of deterioration of the preparation over time. No changes in heart rate over time were observed in the control group (Fig. 1B) . TATHKII also significantly reduced RPP during 25 min peptide perfusion. However, TATHKII was without significant effect on these changes in mechanical performance when compared to vehicle. In contrast, TATHKII treatment resulted in a significant, albeit modest, increase in oxygen consumption as compared to vehicle ( Figure 1D ). No differences in flow or heart weight were present between groups (Table 1 ).
These data demonstrate that acute detachment of HKII from mitochondria in the intact heart increased oxygen consumption with no direct effect on mechanical performance.
Metabolic effects of acute detachment of HKII using TATHKII peptide treatment in ex vivo
Langendorff hearts
Next we evaluated whether acute detachment of HKII from mitochondria affected glucose metabolism. Lactate and pyruvate efflux rate (reflecting glycolysis from exogenous labeled glucose) was low in all hearts, probably due to the lack of insulin in these conditions (Figure 2A ). TATHKII treatment was without significant effect on the rate of anaerobic glycolysis, albeit the rate was reduced by 43% (p=0.28). From the MPE of pyruvate it can be concluded that exogenous glucose contributes 38% to endogenous pyruvate formation, the remainder probably coming from exogenous lactate and pyruvate (table 1) . TATHKII peptide treatment was without effect on the MPE of pyruvate, i.e. the pyruvate formation from glucose. The relative contribution of carbohydrates to
citrate synthesis is depicted in Figure 2B . Carbohydrates contributed approximately 28% to the citrate synthase flux, with the contribution of lactate being 18% and that of glucose 10%. TATHKII treatment resulted in a trend towards a decrease of glucose contribution to citrate synthase flux (p=0.076).
To further explore possible mechanisms for the increased oxygen consumption and reduced glucose metabolism in the TAT-HKII treated hearts, we examined glucose uptake and 13 C intermediates in the two groups of hearts (table 2) . TAT-HKII treatment was associated with a non-significant trend (p=0.131) in decreased glucose uptake, and a significant increase in tissue pyruvate concentration.
Functional effects of chronic partial HKII knockout in ex vivo Langendorff hearts
Mechanical performance and oxygen consumption for WT and HKII +/-hearts are given in Figure 3 .
Peak systolic pressure, heart rate and RPP are not different between the genotypes. Flow and heart weight were also not different between the genotypes (Table 1) . Cardiac oxygen consumption is also not affected by deletion of one HKII copy.
In these insulin and FFA perfused hearts (in addition to glucose, lactate, pyruvate and glutamine) mechanical performance is similar to hearts perfused without insulin and FFA (compare to Fig. 1 ), when comparing baseline conditions between WT and TAT groups. However, adding 100 mU/L insulin and 0.3 mM FFA show a non-significant trend (p=0.084) in lowering cardiac oxygen consumption ( Fig.1D vs Fig. 3D ; 7.6 ± 0.6 vs 6.3 ± 0.4 µmol/min/g ww , respectively).
Metabolic effects of partial HKII knockout in ex vivo Langendorff hearts
Anaerobic glycolysis rates in these hearts perfused with additional insulin and FFA was much higher (0.36 ± 0.02 µmol/min; Fig. 4A ) than in the hearts perfused without insulin and FFA (0.07 ± 0.03 µmol/min; Fig. 2a) , likely due to the presence of the relative high insulin concentration. Partial deletion of HKII was, however, without effect on anaerobic glycolysis rate. Glucose enrichment of
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12 tissue pyruvate (table 1) was not significantly higher than in the hearts perfused without insulin and FFA, and was not affected by genotype (p=0.22). The relative contribution of glucose and palmitate to acetyl-CoA formation for citrate synthesis in TCA cycle is shown in Fig. 4B and 4C, respectively.
Despite the presence of FFA (known to inhibit glucose metabolism), carbohydrate contribution to citrate synthesis was again much higher (61.4 ± 6.9%) in these insulin-perfused hearts as compared to hearts perfused without insulin (28.4 ± 4.5%; Fig 2B) . However, the contribution of glucose, and lactate and pyruvate, to citrate synthesis was not affected by the partial deletion of HKII.
Correspondingly, palmitate contribution to acetyl-CoA formation for citrate synthesis was also similar between the two genotypes (Fig. 4C) .
Consequences of partial HKII knockout on the cardiac transcriptome
In order to study the consequences of deletion of one HKII copy at the transcriptome level, we performed RNAseq analysis of WT and HKII +/--hearts. Analysis of differentially expressed genes revealed a small impact of the partial HKII deletion, with only the decrease in HKII expression reaching the FDR cut off of 0.05 in both limma and DESeq2 (Table 3, showing the first 5 genes with largest tendencies of being differentially expressed between the genotypes). In DESeq2, two more genes, Antxr2 and Kbtbd12, were differentially expressed with small log2 fold changes (0.24 and 0.31, respectively). Given the lack of previous association of these genes with cardiac metabolism and the overall small changes in gene expression in the HKII +/--hearts, the identification of these transcripts as differentially expressed is likely spurious.
Discussion
Although it is well recognized that the degree of mitochondrion-HKII association is sensitive to many cardiac pathologies and interventions (IR, cardioprotection, insulin treatment, diabetes, hypertrophy, heart failure [5] ), the metabolic consequences for the intact heart are, surprisingly, to a large extent unknown. We now report that 1) acute disruption of HKII from mitochondria in intact hearts is associated with an increase in oxygen consumption and a nonsignificant trend of decreased glucose contribution to citrate synthase flux; 2) chronically reduced HKII (including reduced mtHKII) is not associated with alterations in cardiac oxygen consumption,metabolism, or metabolic reprogramming at the transcriptional level of the intact heart not cause.
Acute decreases in mitochondrial hexokinase II and cardiac metabolism
We have demonstrated that acute detachment of HKII from mitochondria increases cardiac oxygen consumption. We are unaware of other studies that have specifically examined the effects of mitochondria-HKII association on oxygen consumption. Our data indicates that HKII attachment to the mitochondria slows down mitochondrial respiration in a functional, working organ. This is commensurate with our previous observations that short periods of ischemia, able to induce cardioprotection and associated with increased mtHKII [25] [26] [27] , result in slower mitochondrial activation of oxygen consumption [28, 29] . This slowing down was only observed with glucose, and not with lactate or pyruvate substrates, suggesting a glycolytic-origin, possibly HKII, of this effect.
Since cardioprotection is associated with increased glucose metabolism [30] , it is then suggested that increased glucose metabolism results in attenuated mitochondrial function. Indeed, in the present study increased binding of HKII to mitochondria was associated with a trend for increased glucose metabolism. It is generally believed that the physical binding of HK to mitochondria increases HK activity through decreasing its K m for ATP, relieve of allosteric inhibition by G6P and glucose-1,6-
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14 biphosphate, and preferential access to mitochondrial produced ATP [2, 31, 32] . HKII binding to mitochondria promoted glycolysis in CHO cells [11] . Increased glucose metabolism could potentially decrease mitochondrial oxygen consumption because of the higher P/O ratio for glucose relative to other substrates (less oxygen needed per ATP produced), or because of increased transport of cytosolic NADH into the mitochondria, which transport may impair oxygen consumption [33] .
Alternatively, the increased oxygen consumption with similar cardiac function could also suggest a lower cardiac efficiency. Although care should be taken for over interpretation, the observed nonsignificant trend for decreased glucose uptake and increased tissue pyruvate concentration with less mtHKII, indicates that the decrease in glucose metabolism with detachment of mtHKII is controlled by impairment of glucose uptake and pyruvate oxidation within the intact heart. The increased oxygen consumption is then likely a result of a decrease in glucose metabolism, which, because no changes in mechanical work were observed, is then compensated with increased FA oxidation with its consequently higher oxygen need to provide similar ATP.
Chronic decreases in (mitochondrial) hexokinase II and cardiac metabolism
In contrast to the acute manipulation of mitochondrial HKII, we observed no changes in oxygen consumption and metabolism in the partial HKII knockout heart, which we previously showed to have 50% less total and mitochondrial HKII [18] . Since chronic reductions in proteins are notorious for inducing compensatory alterations in other genes/proteins, possibly explaining the lack of changes in cardiac metabolism and oxygen consumption with chronic reduction in HKII, we characterized the cardiac transcriptome through RNA sequenching. The absence of differential gene expression demonstrated that compensation at the level of gene expression was absent, negating a role for gene expression adaptation in this model. However, at this stage, we cannot exclude that adaptation did occur posttranscriptonally (proteins and its posttranslational modifications). That cardiac glucose metabolism was unaffected in these partial HKII knockout hearts, is in support of M A N U S C R I P T ACCEPTED MANUSCRIPT 15 previous findings using the similar partial HKII knockout and reporting unaltered cardiac glucose uptake during sedentary conditions in these hearts [8, 34] .
No insulin versus high-dose insulin and cardiac glucose metabolism
In the present study we used perfusion conditions with and without insulin, as dictated by our previous experimental conditions where effects of the HKII manipulations were already determined [17, 18] . The absence of insulin, despite glucose being present at 11 mM, resulted in a rather low rate of anaerobic glycolysis (0.07 ± 0.03 µmol/min) and glucose contribution to acetyl-CoA formation for citrate synthesis (11.2 ± 2.2%), even when compared to other heart studies using glucose-only perfusates. Total carbohydrates (glucose, lactate, pyruvate) contribution to acetyl-CoA formation for citrate synthesis amounted to near 30%, suggesting that a major part of citrate synthesis was derived from endogenous FA oxidation from stored triglycerides. It was shown before that in conditions of glucose-only perfusate myocardial triglyceride turnover contributes significantly to energy production in isolated hearts [35] . The low rates of glucose metabolism are likely due to the presence of 1 mM lactate; physiological concentrations of lactate decrease glucose metabolism to a large extent [36] . The data suggest that in perfusion conditions with glucose and lactate both being present, insulin is needed to facilitate glucose metabolism in the isolated heart. In the presence of insulin and FFA in the perfusate, carbohydrates and FFA acids contributed for 60% and 15%, respectively, to citrate synthesis in the intact hearts. These values are commensurate with values reported before in the isolated working rat heart [21] , although much higher contributions of fatty acids have also commonly been observed. The relatively low fatty acid contribution could be due to the relatively high insulin concentration (100mU/L), the presence of 1 mM lactate (physiological concentration, and often neglected in isolated heart studies), knowing that lactate inhibits fatty acid oxidation [37] , and the low, but physiologically-relevant for the fed condition [38] , fatty acid concentration (0.3 mM).
Methodological considerations
In the current study the effects of modest changes (30-50% decrease) in HKII on cardiac metabolism were examined. These modest HKII changes probably partly explain why only modest or even no changes in cardiac metabolism were observed. Importantly, these modest changes in HKII mimic the changes in HKII that occur during pathophysiological interventions such as IR and ischemic preconditioning [24 -26] , type I and type II diabetes [4] , insulin treatment [24, 39] , or cardiac remodeling during hypertrophy and heart failure [6, 40] . Were we to use a complete knockout of HKII or transgenic overexpression of HKII by more than a factor of 5, larger changes in metabolism would probably have occurred. However, we believe the imposed manipulations of HKII and their metabolic consequences in the current study are more relevant to the real life pathophysiological conditions. In conclusion, our data suggest that an acute, but not chronic, decrease in HKII binding to mitochondria increases cardiac oxygen consumption that is associated with a trend for decreased glucose contribution towards citrate synthesis in the mitochondria.
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